Blood anticoagulant

A blood anticoagulant and pig blood technology, which is applied in the field of pig slaughtering, can solve problems such as processing difficulties, failure, and poor anticoagulant effect, and achieve the effect of solving blood hemolysis and fibrinogen aggregation

Inactive Publication Date: 2014-10-01
桐城市雨润生物科技有限公司
View PDF4 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] After the existing live pigs are slaughtered, the blood is directly discharged into the blood receiving tank to make plasma protein powder. The anticoagulant workers of the enterprise need to carry out anticoagulant work on the blood. The traditional anticoagulant is anticoagulant by adding 4% sodium citrate. The coagulation effect is poor, and the anticoagulant effect will fail within 1-1.5 days, causing blood hemolysis. In addition, the fibrinogen in the anticoagulated blood is prone to coagulation and precipitation, which makes subsequent processing difficult.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0019] A blood anticoagulant, raw materials: 2.63 g of sodium citrate, 0.327 g of citric acid, 2.55 g of glucose, 0.21 g of sodium dihydrogen phosphate, 1.2 g of disodium edetate, and 100 g of water. Add the above raw materials into 100 g of water in turn, dissolve and stir evenly at room temperature. Take 14ml of the blood anticoagulant after stirring and dissolve it in 100ml of pig blood.

Embodiment 2

[0021] A blood anticoagulant, raw materials: 2.5 g of sodium citrate, 0.3 g of citric acid, 2.2 g of glucose, 0.2 g of sodium dihydrogen phosphate, 1 g of disodium edetate, and 100 g of water. Add the above raw materials into 100 g of water in turn, dissolve and stir evenly at room temperature. Take 14ml of the blood anticoagulant after stirring and dissolve it in 100ml of pig blood.

Embodiment 3

[0023] A blood anticoagulant, raw materials: 3 g of sodium citrate, 0.4 g of citric acid, 2.6 g of glucose, 0.25 g of sodium dihydrogen phosphate, 1.5 g of disodium edetate, and 100 g of water. Add the above raw materials into 100 g of water in turn, dissolve and stir evenly at room temperature. Take 14ml of the blood anticoagulant after stirring and dissolve it in 100ml of pig blood.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a blood anticoagulant which consists of the following raw materials in parts by weight: 2.5-3 parts of sodium citrate, 0.3-0.4 part of citric acid, 2.2-2.6 parts of glucose, 0.2-0.25 part of sodium dihydrogen phosphate, 1-1.5 parts of ethylenediamine tetraacetic acid disodium salt and 100 parts of water, wherein the raw materials are sequentially added into 100 parts of water, dissolved and uniformly stirred at normal temperature, and 14ml of the blood anticoagulant is dissolved in 100ml of pig blood. The anticoagulation effect of the blood anticoagulant disclosed by the invention is not less than 3 days, and then the phenomenon of blood hemolysis is solved. By adopting the blood anticoagulant, the fibrinogen aggregation phenomenon of the blood is solved.

Description

[0001] technical field [0002] The invention belongs to the field of pig slaughtering, and relates to a blood anticoagulant, in particular to a blood anticoagulant used in pig blood transportation. Background technique [0003] After the existing live pigs are slaughtered, the blood is directly discharged into the blood receiving tank to make plasma protein powder. The anticoagulant workers of the enterprise need to carry out anticoagulant work on the blood. The traditional anticoagulant is anticoagulant by adding 4% sodium citrate. The coagulation effect is poor, and the anticoagulant effect will fail within 1-1.5 days, causing blood hemolysis. In addition, the fibrinogen in the anticoagulated blood is prone to coagulation and precipitation, resulting in difficulties in subsequent processing. Now, considering factors such as transportation costs, blood generally needs to be transported every 2-3 days, so it is imperative to seek an anticoagulant with better effect. Co...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07K14/47A01N1/02
CPCA01N1/0226
Inventor 崔群维苗雁文高仁清
Owner 桐城市雨润生物科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap